Usefulness of an Initial Single Intravenous Immunoglobulin Infusion with Delayed Use of Aspirin against Kawasaki Disease Relapse: A Single-Center Retrospective Study

Journal Title: Journal of Advanced Research in Medicine - Year 2019, Vol 6, Issue 1

Abstract

Background: Kawasaki Disease (KD) relapse is a risk factor for Coronary Artery Lesion (CAL) development. However, the frequency and outcomes of patients with relapse remain unclear. Objective: To determine the frequency and outcomes of patients with KD relapse and to ascertain the usefulness of treatment with initial single intravenous immunoglobulin (IVIG) therapy (2g/kg) with delayed use of aspirin (DUA).Materials and Methods: The outcomes of 207 patients who underwent initial single IVIG therapy at 2 g/ kg/ dose with DUA for KD were analyzed retrospectively. The patient data were divided according to whether the patients had relapses (relapse group, n=5) or not (non-relapse group, n=202). KD presentations were considered as relapses when a second episode appeared within 2 months of the first one. Stat Flex version 6 for Windows was used for all statistical analyses. Chi-square, Fisher’s exact, and Mann-Whitney U tests were used as appropriate, with sample size considerations.Results: The frequency of patients with disease relapse was 2.4%. The five patients who experienced relapses (two boys and three girls; median age, 10 months; range, 3 months to 3 years 11 months) received initial IVIG therapy at 5 days of illness. The median day of illness for the relapse was 16 (range, 12-29). No patients with disease relapse developed CAL. The rate of incomplete type, IVIG resistance and CAL, and timing of initial IVIG therapy with regard to the days of illness were similar between the relapse group and the non-relapse group. Three parameters, including serum C-reactive protein, albumin values, and Neutrophil-to-Lymphocyte ratio (NLR) before and after initial IVIG, were similar between the two groups. Although not statistically significant (P=0.055), the median NLR after initial IVIG therapy of the relapse group was higher than that of the non-relapse group (2.48 vs. 0.84).Conclusion: An initial single IVIG therapy (2g/ kg/ dose) with DUA for KD may lead to a low KD relapse frequency and to favorable patient outcomes.

Authors and Affiliations

Toshimasa Nakada

Keywords

Related Articles

Lymphatic Filariasis Presenting as Asymptomatic Unilateral Inguinal Swelling

Filariasis is endemic in the tropical areas of the world including India. Its common presentation is lymphadenopathy limited to groin and femoral triangle of thigh and also as filarial lymphoedema of legs. The finding ra...

Unusual Involvement of Lateral Recess of Vertebrae in Potts Spine

Spinal tuberculosis is the commonest manifestation of extra-pulmonary tuberculosis. It usually presents with backache, paraparesis, and spinal deformity. It accounts for 2% of all tuberculosis cases, 15% of extra-pulmona...

Comparison of Eplerenone and Spironolactone in Treatment of Patients with Congestive Heart Failure Visiting a Tertiary Hospital in North India

Background: Congestive heart failure (CHF) is a serious clinical condition, with not many established treatment options. Eplerenone (Inspra) is the second aldosterone antagonist commonly used (in preference to Spironolac...

Acute Stroke as the Initial Presentation of Takayasu Arteritis: Rare but Not Infrequent

Takayasu arteritis is an idiopathic, autoimmune, large vessel vasculitis, mainly affecting the young adults. Its exact etiopathogenesis is not known and it has varied clinical presentations.Acute stroke as initial presen...

Idiopathic Intracranial Hypertension with Multiple Cranial Nerve Involvement: A Clinical Enigma

Idiopathic Intracranial Hypertension (IIH), previously known as Pseudotumor cerebri is characterized by raised intracranial pressure without any obvious reason. Early clinical suspicion and targeted investigations are cr...

Download PDF file
  • EP ID EP669843
  • DOI 10.24321/2349.7181.201905
  • Views 106
  • Downloads 0

How To Cite

Toshimasa Nakada (2019). Usefulness of an Initial Single Intravenous Immunoglobulin Infusion with Delayed Use of Aspirin against Kawasaki Disease Relapse: A Single-Center Retrospective Study. Journal of Advanced Research in Medicine, 6(1), 18-24. https://europub.co.uk/articles/-A-669843